Update on adjuvant trials in the treatment of high-risk colorectal cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical colorectal cancer

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1533-0028(11)70090-1PMID 15025792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

  2004cited by this paper
• Adjuvant chemotherapy in colon cancer: what is the evidence?

  2003cited by this paper
• 1085 Multicenter international randomized study of oxaliplatin/5FU/LV (folfox) in stage II and III colon cancer (mosaic trial): final results

  2003cited by this paper
• First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

  2002cited by this paper
• Future directions in adjuvant therapy for stage III colon carcinoma.

  2001cited by this paper
• Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer.

  2001cited by this paper
• North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.

  2001cited by this paper
• National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.

  2001cited by this paper
• Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel.

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.

  1998cited by this paper
• Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.

  1997cited by this paper

• The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

  2006cites this paper